McKinney TX 肥胖症临床试验
4项针对 肥胖症的研究正在 McKinney及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
招募中2 期
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- North Dallas Research Associates, McKinney
- Texas Institute of Cardiology, McKinney
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
招募中3 期
- Texas Institute of Cardiology, McKinney
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- North Texas Research Associates, McKinney
其他城市的 肥胖症试验
- Houston, TX44 项研究
- Chicago, IL42 项研究
- New York City, NY40 项研究
- San Antonio, TX39 项研究
- Washington, DC33 项研究
- Dallas, TX31 项研究
- Orlando, FL29 项研究
- Boston, MA28 项研究
- Miami, FL27 项研究
- Las Vegas, NV27 项研究
- Atlanta, GA25 项研究
- Jacksonville, FL25 项研究
McKinney的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。